Nektar Therapeutics
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2021
Total Assets: $1.12B
Liabilities Breakdown FY2021
Total Liabilities: $437.7M
Asset Breakdown
Total Assets: $1.12B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $25.2M | 2.3% |
| Accounts Receivable | $22.5M | 2.0% |
| Inventory | $15.8M | 1.4% |
| Property, Plant & Equipment | $60.5M | 5.4% |
| Goodwill | $76.5M | 6.8% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $916.7M | 82.1% |
Liabilities Breakdown
Total Liabilities: $437.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.7M | 2.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $427.9M | 97.8% |